INTRODUCTION:

Some drugs like antipsychotics are administered by intramuscular injections with long-acting effect. Continuous medicine or fluids may be delivered with IV infusions. Parentral drug products include liquids, suspensions, emulsions, sterile solution or suspension powders (including liposomes), implants (including microparticles), and medication and suspension items. Performance checks of goods are conducted to determine characteristics such as measurement, recognition, and uniformity of quality and are part of the compendial requirements. Drug safety evaluations are carried out to determine the release of drugs from the dosage form.(17) Parentral dosage forms differ from all other methods of drug delivery since they are delivered directly into the body tissue through the primary protective mechanism.

Performance checks are conducted to identify attributes such as measurement, recognition, and uniformity of substance, and are part of the compendial specifications.

Advantages:

1. Provide fast drug actions.

2. Provide complete bioavailability of medicines (100 per cent in I.V.).

3. Provide extended actions on the drug.

4. Avoids first pass effect 5 on the hepatic. Relatively minimum concentration of the drug thus

5. comparatively low toxicity.

6. Parentral treatment provides the means to fix serious

7. Both fluid and electronic equilibrium disruptions.

8. Total nutritious when food can not be taken by mouth

Disadvantages:

1. Not easy administration.

2. pain occurs after injection.

3. Generally, medical assistance for administration (such as physician or nurse normally in hospital or clinic) is needed if it is performed by patients themselves and requires good preparation.

4. Strict adherence to aseptic procedures is important.

5. Chances of excessive dosing are greater.

Routes of Administration:

Fig. No. 1: Routes of Administration

Intramuscular route, subcutaneous route, and intravenous route are commonly used as the primary routes of parentral administration. To a large extent these routes fulfill the four basic reasons for prescribing parentrals.

Uses:

For therapy, for prevention, for diagnosis, ions for temporary alteration of the tissues to facilitate other forms of therapy [4]

1. Intramuscular injections:

· Are performed in the muscle tissues. Normally picked shoulder, thigh or buttock muscles.

· This route is mostly used for volume up to 2.0ml and should not exceed 4.0ml at one site. This route can be administered to watery or oily suspensions and oily solutions.

2. Subcutaneous injections:

· Are made in the subcutaneous tissue under the skin. The volume is usually injected into the upper arm by 1.0ml or less.

· This is `the most critical path for the patient and the doctor.

3. Intravenous Injections:

· These injections are delivered into the vein and are therefore immediately absorbed into the systemic circulation.

· Huge volume of parentral solutions that can be pumped from 1 ml to 500 ml or more.

· When amounts of more than 15 ml should be injected, the parentral solution should be isotonic with blood.

4. Intradermal injections:

· ranging from dermis to epidermis are given. Left forearm skin usually chosen for given injection. This route usually injects 0.1 to 0.2 ml of parentral solution.

· These are similar to intravenous injections and are used for an immediate effect on occasion in a peripheral area. These injections are taken directly into the artery.

5. Intracardiac Injections:

· These are used only as a stimulant following cardiac arrest in the heart muscle or ventricle in an emergency.

6. Intrathecal injection:

· These injections are made into subarachnoid anaesthesia of the spinal cord.

7. Intracisternal injections:

· These injections occur between the cervix's first and second vertebrae.

8. Intra- articular injections:

· These are delivered in the liquid that lubricates the bones ‘articulating ends in a joint.

Formulation of Parentral Product^[3]

A. Vehicles:

· Aqueous vehicle

· Non-aqueous vehicle

B. Added substances:

· Antimicrobial agent

· Buffering agent

· Antioxidants

· Tonicity agents

· Cryprotectant

· Suspending Agents

· Emulsifying agent

· Chelating Agents

· Co-solvent

A. Vehicles

Vehicles are two types those are ^[¹⁰^]

· Aqueous vehicles.

· Non-aqueous vehicles

· Aqueous vehicles:

Widely used vehicle for parentral preparations is water and is the most suitable since aqueous preparations are well metabolised by the liver and they are not dangerous to be used

Different types of water used include:

1. Injectable water.

2. Sterile injectable water.

3. Bacteriostatic injectable water.

· Non-aqueous vehicles:

Aqueous vehicles are preferred for parentral preparations, but it is sometimes necessary to eliminate water from certain preparations for one of the following reasons:

1. To increase the solubility of certain poorly water-soluble drugs by replacing water with other nonaqueous vehicles.

Nonaqueous vehicles used in parentral preparations include:

1. Water miscible vehicles.

2. Water immiscible vehicles

B. Added Substances:

Substances added to a product to enhance its stability are essential for almost every product such substances include solubilzers, anti oxidants, chelating agents, buffuering agent, tonicity factors. anti microbial agents, anti fungal agents, antifoaming agents for specialized purposes.

· Anti microbial agents:

These agent’s formulation shall include the bacteriostatic concentration of products packaged in multiple dose vials and are mostly involved in formulations to be sterilized by marginal processes.

Table No.1: Antimicrobials used for parentral products

Preservative	Typical Concentration (%w/v)
Benzalkonium Chloride	0.01
Benzoic Acid	0.17
Benzyl Alcohol	1-2
Chlorobutanol	0.1-0.5
Chlorocresol	0.1
Cresol	0.15-0.3

· Buffers:

These are used to protect the solution against chemical degradation or, in particular, for proteins, high physical degradation occurring as pH increases. The buffer system used should usually have as little buffering power as possible so that the body's buffering mechanism is not greatly disrupted when injected (7)

· Antioxidants:

Antioxidants are added, to prevent the parentral substance from oxidizing. Ascorbic acid and its salts are excellent antioxidants. These are often needed to maintain products because they are easy to oxidise with many drugs. (4)

E.g.: Ascorbic acid, Sodium bisulfate, EDTA.

· Tonicity Agents:

Tonicity agents are used in many Parentrals and Ophthalmic products to adjust the isotonicity of the solution.Parentral preparations should be isotonic with blood streem or other body fluids to minimize inflammation and injection pain in areas with nerve endings, adding sodium chloride, borax etc. can change the isotonicity of a solution. The agents most commonly used are electrolytes and mono saccharides or disaccharides.(4)

· Cryprotectants and Lyoprotectant:

These are additives that protect biopharmaceuticals during freezing dry processes from adverse effects due to freezing and drying of the product.

E.g. Sugar like sucrose, amino acid like glycine, lysine, etc.

Solid polymers include polyethylene glycol, dextran, other polyols as, mannitol, sorbital. (9)

· Suspending Agents:

A wetting agent is used in a Parentral suspension to decrease the interfacial stress between the solid particles and the liquid to avoid lump formation.They also act as antifoaming agents to subside the foam produced during shaking of the preparation these agents are used or Twin and sorbital, Suspending agents Methyl cellulose, Carboxyl Methyl cellulose, Acacia, Gelatin. (9)

· Emulsifying Agents:

Emulsifying agents are used in sterile emulsions. For this purpose lecithin is generally used.

· Stabilizers:

Stability of a drug may also be characterized as the extent from the day of preparation and packaging of the product till its chemical or biological activity is no less than a given degree of labeled efficacy and its physical characteristics have not significantly or deleteriouslyh altered. Oxidation and hydrolysis of medications happens more rapidly when in the form of a solution.

· Solubilising agents:

The solubility of insoluble or poorly soluble in water can be increased by co- Solvents. Complex formation or by adding surfactants like Tweens, Polysorbets etc.which act by solubilization.

Table No. 2: Solubility Enhancer

Terms	Relative Amount of Solvent to solubilize single Part of Solute
Very soluble	<1
Freely soluble	1-10
Soluble	10-30
Sparingly soluble	30-100
Slightly soluble	100-1000
Very slightly soluble	1000-10000
Practically soluble or Insoluble	>10000

Processing a parentral dosage forms:

Sterile product area design and function:

· Clean room: These areas are specially screened and held to prevent contamination of sterile goods by the atmosphere.

· Laminar flow is of two types:

· Horizontal hoods with laminar flow

· Vertical hoods with laminar flow

· User area: for short-term keeping of lots before and after sterilization o Service area: for chamber lagging sterilizer during maintenance and removal for regular insurance purposes, steam, water, etc.

· Inspection and marking area: for optimum visible particulate pollution detection but a.lso for adequate inspection.

· Quarentium store: For the batches in process should be arranged here like a drug store. Changing facilities for a socially clean area: many of the fundamental principles of clearing will be applied and aseptic areas will also apply to socially clean area

· Sterility testing: ensures that the process used to sterilize the product was successful.

· Pyrogen testing: The qualitative fever response test in rabbit sand also makes it difficult to carry out an invitro limulus test because of less facility.

· Clarity testing: it is used to inspect sterile goods for quality control and preservation of particulate matter. Quality control is a day-to-day evaluation of all activities from the procurement of raw material to the delivery of materials.

· Quality assurance an oversight function, involves the auditing of quality control procedure and systems, with suggestions for changes as needed methods of sterilization

· Sterilization is performed to destroy or remove all microorganisms in or on a product.

· Thermal sterilization consist of moist or dry heat

· Moist heat sterilization: Heating the objects in boiling water. By this method microorganisms are destroyed by cellular protein coagulation.

· Dry heat sterilization: It is particular for materials that may not be moist heat sterilization.

Chemical sterilization:

Used for surface sterilization and porous content. In general, ethylene oxide is used in conjunction with heat and humidity.

Household gas must be permitted to dissipate after sterilization

Radiation sterilization:

Ideal for industrial sterilization of contents or sealed packages not subject to heat exposure.

Evaluation test for parentrals:

The quality control test in process includes the testing for leakage and clarity. Finished product quality control required the pyrogen and sterility tests.

Fig. No. 1: Layout of Parentral Manufacturing Area

1. Leakage Test:⁽¹⁾

Fig. No. 2: Leakage test apparatus

Leakage screening is used to verify package integrity. The box's consistency reflects the ability to keep the product in and avoid contamination in the future. It's because leakage happens when there's discontinuity in the wall of a package that can allow the gas to pass through the wall under pressure or differential concentration.

2. Clarity Test:⁽⁴⁾

The preparations for parentrals should be free of particulate matter in the range of 30-40 micrometers and larger particles. USP states that all containers should be visually inspected for visible particles and discarded if present. In large volume parentrals the USP states a limit of fifty particles of 10 micrometers and larger; and 25 micrometers and larger particles per ml.

3. pH:⁽⁶⁾

The pH is measured by pH meter. First the pH meter apparatus is calibrated with the corresponding buffer bottle, then the pH of the measured preparations. pH is the calculation of the concentration of protons (H+) in a hydrogen-potential solution. It is defining a material by using an acidity scale from 0 to 14, how acidic or alkaline it is. Less acidic solutions which have less pH

4. Sterility Test:

Sterility can be defined as the freedom from the existance of living microorganisms. This is done to detect the presence in parentral products of living forms of bacteria, fungi and yeast. The Sterility test must be conducted under controlled sterilized conditions to avoid accidental product contamination during testing. All glassware needed for testing must be Sterile.

Sterility test methods:

1. Membrane filtration method

2. Direct inoculation method

1. Membrane filtration methods:

Fig. No. 3: membrane filteration method

The most commonly used method of membrane filteration. Compared to the direct inoculation method, it requires more skill and knowledge for efficient employment. This process basically involves filtration of samples with hydrophobic characters through 0.22 micron membrane filters and 47 mm diameter. In vacuum the filtration is aided. The membrane is divided into two halves and set in two test tubes containing culture medium after filtration is over.

It involves direct inoculation of a sample's required volume in two test tubes that contain the aculture medium. This approach is theoretically easy but technically tough due to continuous container opening, sample transfer and mixing which can contribute to the operator's possible exhaustion and operator technique deterioration. There are chances of for contamination due to all this.

3. Test For Pyrogens/Endotoxins:⁽¹⁹⁾

Pyrogen: In Greek "Pyro" = fire, "gen" = starting A Pyrogen is a substance, i.e. products of the growth of microorganisms, or parts of dead cells or metabolic products that cause febrilereactions such as fever, chills, back pain etc.

· Sources of Pyrogens and its destruction methods:

The Pyrogen test is designed to limit the risk of febrile reaction following drug administration at parentral level.

It includes both In vitro and In vivo tests.

1. In Vitro Test/limulate ameobocyte lysate Test

2. In Vivo Test/sham Test

CONCLUSION:

The most common and effective route for the delivery of active pharmaceutical substances with a narrow therapeutic index is the parentral route of administration, poor bioavailability especially for those drugs, prescribed for rapid response to unconscious patients. Basic parentral products are typically sterile, pyrogen-free, particle-free, stable, isotonic and healthy. All these characteristics are improved and ensured in the preparation of these items by following proper sterile procedures.

· Controlled and targeted drug delivery systems include implants, oily injections, or particulate systems such as microparticles, nanoparticles, liposomes, micelles etc.

· Controlled and targeted delivery of drugs via parentral route is advantageous in the treatment of various disorders but the safety issues and lack of regulations are the main obstacles to their development. The final specifications must ensure the drug product's safety, identity, strength, performance and quality at release and during storage through the end of its shelf life.

REFERENCE:

1. Samesh AS Alariqi. Stabilization of Gamma –Sterilized EPDM by Synergistic Mixtures of Food- contact approved Stabilizers. Asian J. Research Chem. 3(1): Jan.-Mar. 2010, page 205-213.

2. Som Shankar Dubey. Remove on Removal of Radiotoxic Ions from Aqueous Solutions. Asian J. Research Chem. 2019; 12(1):37-40.

3. MH Dehghan, Varsha M Gaikwad, Baby Dandge. Nasal Absorption of Drugs – Barriers and Solutions. Research J. Pharm. and Tech .2(4): Oct.-Dec. 2009; Page 634-641.

4. Naik JB, Mokale VJ, More DB, Bari MM, Chavhan RB, More BB. Failure of Coated Pellets into Tablets – Problems and Solutions. Research J. Pharm. and Tech. 4 (1): January 2011; Page 43-46.

5. G.I. Borshchevsky, T.G. Yarnykh. Justification for the Choice of Excipients of Injectable Solution Based on Essential Phospholipids. Research J. Pharm. and Tech. 9(1): Jan., 2016; Page 01-04.

6. Shreya. S, C. Kanthaswami. Lesion Sterilization and Tissue Repair- A Review. Research J. Pharm. and Tech. 2017; 10(5): 1539-1542.

7. Bibhuti Sonowal, Pulak Deb, Suvakanta Dash. Studies on In-Situ Forming Thermo Sensitive Injectable Polymeric gel for Sustained Drug Delivery. Research J. Pharm. and Tech.2017; 10 (6): 1840-1847.

8. Sneha Thomas, R. Selvakumar, S Mahendran. Formulation and Evolution of an Injectable Dosage Form. Res. J. Pharma. Dosage Forms and Tech.2019; 11(1);47-52.

9. Deepmala, H.K. Pathak. On Solutions of Some Functional-Integral Equation in Banach Algebra. Research J. Science and Tech 5(3): July-Sept., 2013 page 358-362.

10. Niyati Gurudwan. Approximating solutions for the system of ᶲ-strongly accretive operator equations. Research J. Science and Tech 5(3): July-Sept., 2013 page 357-383.

11. Amrutha A.V, Gangadharappa H.V, Kiran H.C, Shuchithra S; “In-Process and Finished Products Quality Control Tests for Sterile and Non Sterile Dosage Form”; Volume-45(1), July-August 2017, Page no. 206-214.

12. Prevesh Kumar, Pawan singh and Mr. Mohd. Semimum Akthar; “International Journal of Advanced Research (Ijar)”; Vol-4(9), Page no.983-998.

13. Sujata D. Dongare, Sachin S. Mali, Prasad V. Patrekar; “Sterile Parentral Products: A Narrative Approach"; Vol-5(1), 13 Jan 2015, Page no. 41-48.

14. Pharmaceutics-II; R. M. Mehta, Page no.244-268.

15. Rajesh. M, Lakshmi.M, Anju S., Palanichamy.S and Solairaj P. “Parentrals – A Versatile and Promising Drug Delivery System”; Volume 3, Issue-5, 24 April 2014, Page no.481-505.

16. Mr. Sagar Kishor Savale; “In Process Quality Control Tests (IPQC) for Parentral or Sterile Dosage Forms”;13 October 2018, Page no.1-26

17. Anu Kaushik, Vivek Chauhan, “Recent Review on Parentral Products- Sterile Dosage Form”; Vol-3, Issue-1 2017, Page no.970-975.

18. Sagar R. Banode, 1 Moein S. Attar, 2 Girish Picche1, “Brief Review of Different Typesof Parentral Devices”; Vol. 6, 8 Aug 2015, Page no.1133-1139.

19. T. Balakrishna et al, a review on pharmacuetical containers and closures, indo AM SP-(sci, 2016; 318)

20. Roop K Khar,SP Vyas,Farhan J Ahmad, Gaurav K Jain; “The Theory And Practice Of Industrial Pharmacy”; edition 4th,2013,

21. Loyd V. Allen, Jr., Nichilas G. Popovich, Hopward C. Ansel, dosage form of drug delievery system”, 9th edition, 2011.

22. Heyam Saad Ali; “A Comprehensive Review in Parentral Formulations”; Volume 3, Issue 1, January 2019, Page no 43-49’

23. Vinod P. Shah, James DeMuth, and Desmond G. Hunt, Performance Test for Parentral Dosage Forms”; November 2015, Page no-16-21.

24. Desmond Hunt; “Injections and Implanted Drug Products (Parentrals)- Product Quality Tests”; May 1, 2016, Page no-1-5.

Received on 14.02.2020 Modified on 11.05.2020

Asian J. Res. Pharm. Sci. 2021; 11(1):45-50.

DOI: 10.5958/2231-5659.2021.00008.4